ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

Tighter Payment Policy

November 5, 2010

Did The Dog Eat It? NIH Fails To Turn In A Prostate Cancer Plan Assigned By Senate

April 23, 1999

NIH Plans Grants For Those Who Barely Miss Payline

April 19, 1991

Smoking Intensity and Markers Predict Cancer Aggressiveness

January 25, 2013

NCI Adds New Wrinkle To Drug Distribution Plan – Individual Investigators To Work Through Centers

March 25, 1977

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

May 2, 2003